Indicates urinary tract infection
(Some clinical literature has suggested the potential of GLP-1-type drugs in the treatment of addiction, attributable to their ability to rewire dopamine signaling in the brain.) Less desirable side effects reported, in trials and anecdotally, include low energy, dizziness, cutaneous hyperesthesia (a form of extreme sensitivity to touch), and decreased libido
Analysts are increasingly viewing retatrutide not simply as a competitor to Zepbound, but as a potential successor within Eli Lillys own metabolic franchise
If you dont have insurance, consider speaking with the provider about financing options and discounts for self-payers
Ann Dermatol
Hedberg-Oldfors C, Eliasdottir O, Geijer M, Lindberg C, Oldfors A (2022) Dominantly inherited myosin IIa myopathy caused by aberrant splicing of MYH2